Biomining 2007
DOI: 10.1007/978-3-540-34911-2_2
|View full text |Cite
|
Sign up to set email alerts
|

Bioleaching of a Cobalt-Containing Pyrite in Stirred Reactors: a Case Study from Laboratory Scale to Industrial Application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
42
1
1

Year Published

2009
2009
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(44 citation statements)
references
References 14 publications
0
42
1
1
Order By: Relevance
“…One way to perform bioleaching is the continuous stirred tank reactor technology (CSTR). It is a commercial reality for the treatment of refractory gold ore concentrates (Arrascue and van Niekerk 2006;van Aswegen et al 2007), but has also been used in one case for the treatment of a cobalt-rich pyrite concentrate (Morin and d'Hugues 2007). Bioleaching in CSTR represents an attractive alternative to conventional roasting or pressure oxidation techniques because it offers several advantages: operational simplicity, lower capital and operating costs, environment friendliness and suitability for the treatment of complex and low grade ores Watling 2006).…”
Section: Introductionmentioning
confidence: 99%
“…One way to perform bioleaching is the continuous stirred tank reactor technology (CSTR). It is a commercial reality for the treatment of refractory gold ore concentrates (Arrascue and van Niekerk 2006;van Aswegen et al 2007), but has also been used in one case for the treatment of a cobalt-rich pyrite concentrate (Morin and d'Hugues 2007). Bioleaching in CSTR represents an attractive alternative to conventional roasting or pressure oxidation techniques because it offers several advantages: operational simplicity, lower capital and operating costs, environment friendliness and suitability for the treatment of complex and low grade ores Watling 2006).…”
Section: Introductionmentioning
confidence: 99%
“…However, this represents a greater capacity than the one of current bioleaching installations. For example, the BIOX operations treat gold concentrate flowrates between 13 000 and 320 000 t/y (van Aswegen et al, 2007) and the Kasese cobalt production plant is oxidizing 82 000 t/y of pyrite concentrate (Morin et d'Hugues, 2007). It is worth noting that above 200 000 to 250 000 t/y capacity, bioleaching processes (more particularly Biocop process) tend to reach their limits of application when compared to smelting (Clark et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…The culture used in this study originated from a mixture of two consortia cultured for many years on both a cobaltiferous pyrite and a copper concentrate (d 'Hugues et al, 2003;Morin and d'Hugues, 2007). It was subcultured several times in batch mode on the polish copper concentrate before being used as an inoculum in the continuous test.…”
Section: Bioshale-brgm Bacterial Consortiummentioning
confidence: 99%
“…Nevertheless, base-metals processes have been developed to pilot and demonstration scale for the bioleaching of copper ( Figure 5), nickel and zinc sulfide concentrates using mesophiles, moderate thermophiles and thermophiles [128,[182][183][184][185][186] and a process for the extraction of Co from pyrite concentrate has been commercialised [187].…”
Section: Technology Developmentsmentioning
confidence: 99%